A carregar...
Nusinersen Wearing-Off in Adult 5q-Spinal Muscular Atrophy Patients
The antisense oligonucleotide nusinersen was the first drug treatment available for all types of 5q-spinal muscular atrophy (SMA). The dosing regime has been derived from pivotal clinical trials in infants and children. The efficacy of nusinersen in severely affected adult SMA patients is still ques...
Na minha lista:
| Publicado no: | Brain Sci |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7998943/ https://ncbi.nlm.nih.gov/pubmed/33805645 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/brainsci11030367 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|